A new study has found that certain prostate cancer medications are linked with an increased risk of dying from heart-related causes in men with congestive heart failure or prior heart … Continue Reading Prostate cancer medications linked to increased heart-related death risk.
The US FDA has cleared the first ever direct blood test for detection of five yeast pathogens that cause bloodstream infections; Candida albicans and/or Candida tropicalis, Candida parapsilosis, Candida glabrata … Continue Reading FDA clears the world’s first test to identify five yeast pathogens directly from blood.
The US FDA has approved Contrave (naltrexone hydrochloride and bupropion hydrochloride extended-release tablets) as treatment option for chronic weight management in addition to a reduced-calorie diet and physical activity. The … Continue Reading FDA approves weight-management drug Contrave.
A new breast cancer vaccine candidate, (GP2), provides further evidence of the potential of immunotherapy in preventing disease recurrence. This is especially the case for high-risk patients when it is … Continue Reading Novel vaccine decreases recurrence in HER2 breast cancer patients.
The US FDA has cleared the NephroCheck test, a first-of-a-kind laboratory test to help determine if critically ill hospitalized patients are at risk of developing moderate to severe acute kidney … Continue Reading The FDA clears first-ever test to assess risk of developing acute kidney injury.
An experimental drug designed to help regulate the blood’s iron supply shows promise as a viable first treatment for anemia of inflammation, according to results from the first human study … Continue Reading Drug represents first potential treatment for common anemia.